9 patents
Utility
Selection of Patients for Combination Therapy
2 Mar 23
Described herein are methods for selecting cancer patients for treatment with a combination therapy comprising entinostat and a second therapeutic agent.
Peter ORDENTLICH
Filed: 29 Mar 22
Utility
Antibodies for the Treatment of Chronic Graft Versus Host Disease
2 Feb 23
The present invention relates to methods of treating sclerotic conditions and more specifically to methods of treating chronic graft versus host disease with specific dosages of an anti-CSF-1R antibody, specifically axatilimab.
Peter ORDENTLICH, Michael MEYERS, Briggs W. MORRISON
Filed: 9 Dec 20
Utility
Combination of Hdac Inhibitor and ANTI-PD-1 Antibody for Treatment of Cancer
26 Jan 23
Described herein are methods for the treatment of cancer in a subject.
Robert GOODENOW, Peter ORDENTLICH
Filed: 8 Apr 22
Utility
Inhibitors of the Menin-mll Interaction
26 Jan 23
Gerard M. MCGEEHAN, William H. MILLER, Nicholas Paul CAMP, Salvacion CACATIAN, Santosh S. KULKARNI, Swapan Kumar SAMANTA, Virsinha Venkat REDDY
Filed: 13 May 22
Utility
Selection of patients for combination therapy
26 Jul 22
Described herein are methods for selecting cancer patients for treatment with a combination therapy comprising entinostat and a second therapeutic agent.
Peter Ordentlich
Filed: 2 Sep 16
Utility
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
10 May 22
Described herein are methods for the treatment of cancer in a subject.
Robert Goodenow, Peter Ordentlich
Filed: 18 Mar 16
Utility
Selection of Patients for Combination Therapy
5 Aug 21
Described herein are methods for selecting cancer patients for treatment with a combination therapy comprising an HDAC inhibitor and a second therapeutic agent.
Peter ORDENTLICH, Lei WANG, Serap SANKOH, Michael MEYERS
Filed: 7 May 19
Utility
Combination Therapies
3 Jun 20
The present disclosure relates to a combination of an anti-CSF-1R antibody or anti-CSF-1 antibody or antigen binding fragment thereof or an inhibitor of CSF-1R activity and an HDAC inhibitor, e.g., entinostat, and methods of using the combination for administering to subjects in need thereof for the treatment of cancer.
Peter ORDENTLICH, Lei WANG
Filed: 17 May 18
Utility
Methods for the Treatment of Breast Cancer
13 Nov 19
Described herein are methods for the treatment of breast cancer in a subject.
Robert GOODENOW, Peter ORDENTLICH
Filed: 14 Jan 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first